LRA Joins NIAMS Coalition in Supporting Congressional Act Promoting Clinical Trial Diversity

The Lupus Research Alliance and Lupus Therapeutics support diversity in clinical trials to ensure that populations that test potential treatments reflect the population with the disease.

LRA joined 42 other members of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Coalition in sending a letter to Congresswoman Robin L. Kelly in support of the National Institutes of Health (NIH) Clinical Trial Diversity Act (H.R. 3503) that she sponsored. Read the letter sent to Congresswoman Kelly — Coalition Support Letter – NIH Clinical Trial Diversity Act Sign On Letter.

Learn more about the LRA’s advocacy efforts on Capitol Hill here Action Center – Fighting Lupus | Lupus Research Alliance

Recent Stories & News

News Update
Letter from LRA President & CEO Albert T. Roy
May 1, 2025
Dear Friends, Lupus Awareness Month officially starts today, and with a growing coalition of people like you passionately working together...
Story
Simple Ways to Ease Stress with Lupus: Tips from Priscilla Calvache, LCSW
Tips to Lower Stress During Stress Awareness Month and Beyond
April 15, 2025
If you have lupus and often feel stressed, you're not alone! Research shows stress is common among people dealing...
Story
Community inspiration: Ali Vanderloop
Turning Diagnosis into Drive: A Community Member’s Journey that’s Accelerating Lupus Research
April 21, 2025
Like many in the lupus community, one new member, Ali VanderLoop, is turning a difficult diagnosis into powerful action...
Stay informed about events, research developments, and ways you can help. Sign up for updates